Skip to main content
Watch Insiders
ORMPHealthcare

Oramed Pharmaceuticals, Inc (ORMP) Insider Trading

In the last 90 days, 2 Oramed Pharmaceuticals, Inc (ORMP) insiders reported no open-market purchases and 2 sales totaling $225,530. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 1, 2026Avraham GabayChief Financial OfficerSale20,000$4.51$90,200
Oct 1, 2026Joshua HexterCOO & CBOSale30,000$4.51$135,330
Jul 1, 2026Joshua HexterCOO & CBOSale137,000$4.46$611,431
Jul 1, 2026Avraham GabayChief Financial OfficerSale73,360$4.51$330,744

Common questions

ORMP insider trading FAQ

Are ORMP insiders buying or selling?
Over the last 90 days, ORMP insiders were net sellers, reporting $0.00 of open-market purchases and $225,530 of sales.
When was the last ORMP insider purchase?
No open-market insider purchase of Oramed Pharmaceuticals, Inc stock was reported in the last 90 days.
Where does ORMP insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Oramed Pharmaceuticals, Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.